FDA
-
-
-
-
-
-
-
Clarus Therapeutics (CRXT) Announces Issuance of Patent Covering JATENZO
-
-
-
-
-
-
-
Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate)
-
-
-
-
-
-
-
Clarus Therapeutics Announces Issuance of Two New Patents for JATENZO® (testosterone undecanoate)
-
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

